Target intelligence / Profile preview

Ribosomal protein L27a pseudogene 4 (RPL27AP4)

Target
RPL27AP4
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein L27a pseudogene 4 (RPL27AP4) is a *processed pseudogene* of the **ribosomal protein L27a** gene family[10][6][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they usually do not produce functional proteins due to mutations or lack of regulatory elements[2]. RPL27AP4, as a pseudogene, does not encode a functional ribosomal protein and has no known biological or therapeutic relevance in humans[10][6]. It is not a receptor, enzyme, or other typical therapeutic target. There is no evidence for a protein product, involvement in signal transduction, or disease association. Pseudogenes like RPL27AP4 may sometimes be transcribed to noncoding RNA, but no solid evidence exists for a functional product from this locus[2][10]. - The canonical protein-coding gene **RPL27A** encodes the ribosomal protein L27a, which is a component of the 60S large ribosomal subunit[3][4]. RPL27AP4, in contrast, is a *pseudogene*—meaning it is a non-functional copy, and not a target for pharmacological modulation[6][10]. - There is no evidence that RPL27AP4 is misspelled or misassigned, but it should not be considered a druggable or functionally relevant target in biomedical research.

Other names
RPL27A_2_255RPL27AP4
02

Mechanism of action

Not applicable

03

Biological functions

Other (no established biological function; classified as a processed pseudogene)
04

Disease associations

Other (no confirmed role in disease)

Beyond the preview

Go deeper on Ribosomal protein L27a pseudogene 4 (RPL27AP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L27a pseudogene 4 (RPL27AP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call